No abstract available
MeSH terms
-
Endpoint Determination*
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Kaplan-Meier Estimate
-
Proportional Hazards Models
-
Randomized Controlled Trials as Topic*
-
Rosiglitazone
-
Thiazolidinediones / therapeutic use
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone